本页面由Tiger Trade Technology Pte. Ltd.提供服务

奥麦罗制药

18.88
-0.7500-3.82%
盘后:18.980.1006+0.53%16:59 EDT
成交量:99.40万
成交额:1,918.29万
市值:13.66亿
市盈率:12.02
高:19.78
开:19.50
低:18.83
收:19.63
52周最高:21.24
52周最低:4.06
股本:7,237.54万
流通股本:6,825.80万
量比:1.13
换手率:1.46%
股息:- -
股息率:- -
每股收益(TTM):1.57
每股收益(LYR):-0.0527
净资产收益率:-576.33%
总资产收益率:-18.68%
市净率:-26.61
市盈率(LYR):-357.94

数据加载中...

2026/09/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/14

重要事件披露

Form 8-K - Current report
2026/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/07/30

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/20

重要事件披露

Form 8-K - Current report
2026/07/06

重要事件披露

Form 8-K - Current report
2026/06/25

重要事件披露

Form 8-K - Current report
2026/06/18

重要事件披露

Form 8-K - Current report
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]